Find trials
Search tips

Accuracy of Three-Dimensional Ultrasound in Measuring Total Kidney Volume in Children With Autosomal Dominant Polycystic Kidney Disease

Overview

About this study

The purpose of this study is to assess the accuracy of three-dimensional ultrasound (3D US) in measuring total kidney volume (TKV) in children with autosomal dominant polycystic kidney disease (ADPKD).  We will obtain MR-based measurements of TKV as the goal standard by which we will evaluate the accuracy of the 3D US based measurements. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Any ADPKD patient (ages 9-18 years) with confirmed ADPKD (via a combination of imaging, family history, and/or genetic testing), identified from existing and newly identified families for the proposed study.

Exclusion Criteria: 

  • ADPKD patients with liver and or kidney transplant.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/23/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Christian Hanna, M.D., M.S.

Open for enrollment

Contact information:

Ryan Helland

(507) 422-3998

Helland.Ryan@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20559023

Mayo Clinic Footer